Journey Medical (DERM) Research & Development (2021 - 2025)
Journey Medical (DERM) posted Research & Development of $154000.0 for Q4 2025, down 46.34% on a QoQ basis from $287000.0 in Q3 2025, and down 29.36% year-over-year from $218000.0 in Q4 2024.
Journey Medical (DERM) Research & Development (2021 - 2025) Analysis & Trends
Journey Medical's Research & Development history runs 5 years deep, the most recent figure standing at $154000.0 for Q4 2025.
- Quarterly Research & Development fell 29.36% year-over-year to $154000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $480000.0 (down 95.13% YoY) and the FY2025 annual result came in at $480000.0, down 95.13% from the prior year.
- Research & Development was $154000.0 for Q4 2025 at Journey Medical, down from $287000.0 in the prior quarter.
- Across five years, Research & Development topped out at $7.9 million in Q1 2024 and bottomed at $29000.0 in Q2 2021.
- A 5-year average of $1.8 million and a median of $1.4 million in 2022 frame the typical range for Research & Development.
- Annual changes were most pronounced in 2022 — Research & Development jumped 8896.55% — and 2025, when it slumped 99.51%.
- Journey Medical's Research & Development stood at $2.0 million in 2021, then soared by 113.65% to $4.3 million in 2022, then tumbled by 64.64% to $1.5 million in 2023, then sank by 85.51% to $218000.0 in 2024, then slipped by 29.36% to $154000.0 in 2025.
- Business Quant data shows DERM's Research & Development at $154000.0 in Q4 2025, $287000.0 in Q3 2025, and $39000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | 696.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 180.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 7.37 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | 138.20 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 248.60 Mn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 296.20 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | 97.00 Mn |
| 10 | Journey Medical | 169.02 Mn | 141.80 Mn | 9.70 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 154,000.00 |
| Sep 30, 2025 | 287,000.00 |
| Mar 31, 2025 | 39,000.00 |
| Dec 31, 2024 | 218,000.00 |
| Sep 30, 2024 | 842,000.00 |
| Jun 30, 2024 | 913,000.00 |
| Mar 31, 2024 | 7.88 Mn |
| Dec 31, 2023 | 1.51 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 1.77 Mn |
| Mar 31, 2023 | 2.03 Mn |
| Dec 31, 2022 | 4.26 Mn |
| Sep 30, 2022 | 2.81 Mn |
| Jun 30, 2022 | 2.61 Mn |
| Mar 31, 2022 | 1.27 Mn |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 718,000.00 |
| Jun 30, 2021 | 29,000.00 |